Researchers have hailed the results of a new study on a once-a-day weight loss pill as an “important advancement” in type 2 diabetes care.
A new study compared the medication, named orforglipron, against the only existing tablet version of a GLP-1 receptor agonist – a type of medication prescribed for controlling blood sugar and weight loss.